Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-13 11:15 am Sale | 2026-03-31 | 13G | RALLYBIO CORP COM RLYB | JOHNSON & JOHNSON JNJ | 152,901 2.900% | -3,483,462 (-95.80%) | Filing History |
| 2026-03-26 10:05 am Sale | 2026-03-13 | 13G | JOHNSON AND JOHNSON JNJ | VANGUARD GROUP INC | 0 0.000% | -243,455,135 (Position Closed) | Filing History |
| 2026-02-05 12:23 pm Purchase | 2026-01-30 | 13G | JOHNSON AND JOHNSON JNJ | VANGUARD GROUP INC | 243,455,135 10.100% | 14,082,576 (+6.14%) | Filing History |
| 2026-01-12 7:51 pm Sale | 2025-12-31 | 13G | CVRX INC CVRX | JOHNSON & JOHNSON JNJ | 4,024,861 15.400% | -78,569 (-1.91%) | Filing History |
| 2025-10-22 5:09 pm Sale | 2025-09-30 | 13G | RAPPORT THERAPEUTICS INC RAPP | JOHNSON & JOHNSON JNJ | 1,784,517 4.900% | -713,534 (-28.56%) | Filing History |
| 2024-11-01 11:05 am Sale | 2024-09-30 | 13G | CVRX INC CVRX | JOHNSON & JOHNSON JNJ | 4,103,430 17.000% | -5,906 (-0.14%) | Filing History |
| 2024-10-18 5:23 pm Purchase | 2024-09-30 | 13G | RAPPORT THERAPEUTICS INC RAPP | JOHNSON & JOHNSON JNJ | 2,498,051 6.800% | 2,498,051 (New Position) | Filing History |
| 2024-10-18 4:47 pm Unchanged | 2024-09-30 | 13G | MEIRAGTX HLDGS PLC MGTX | JOHNSON & JOHNSON JNJ | 6,641,064 8.600% | 0 (Unchanged) | Filing History |
| 2024-07-30 9:06 pm Purchase | 2024-04-10 | 13G | RALLYBIO CORP COM RLYB | JOHNSON & JOHNSON JNJ | 454,545 8.800% | 454,545 (New Position) | Filing History |
| 2024-05-20 5:17 pm Sale | 2024-05-17 | 13G | KENVUE INC KVUE | JOHNSON & JOHNSON JNJ | 0 0.000% | -182,329,550 (Position Closed) | Filing History |
| 2024-04-10 5:12 pm Purchase | 2024-04-09 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | JOHNSON & JOHNSON JNJ | 1,979,173 10.700% | 1,979,173 (New Position) | Filing History |
| 2024-02-13 5:07 pm Sale | 2023-12-29 | 13G | JOHNSON AND JOHNSON JNJ | VANGUARD GROUP INC | 229,372,559 9.530% | -17,454,062 (-7.07%) | Filing History |
| 2024-02-02 5:07 pm Sale | 2023-12-31 | 13G | BIOMX INC PHGE | JOHNSON & JOHNSON JNJ | 11,123 4.600% | -105 (-0.94%) | Filing History |
| 2024-02-02 4:52 pm Sale | 2023-12-31 | 13G | CVRX INC CVRX | JOHNSON & JOHNSON JNJ | 4,109,336 19.200% | -237 (-0.01%) | Filing History |
| 2024-02-02 4:32 pm Purchase | 2023-12-31 | 13G | NANOBIOTIX S A SPONSORED ADS NBTX | JOHNSON & JOHNSON JNJ | 5,623,816 11.900% | 5,623,816 (New Position) | Filing History |
| 2024-01-30 12:46 pm Sale | 2023-12-31 | 13G | JOHNSON AND JOHNSON JNJ | STATE STREET CORP STT | 132,996,283 5.520% | -9,451,661 (-6.64%) | Filing History |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | JOHNSON AND JOHNSON JNJ | BlackRock Inc. BLK | 186,308,341 7.700% | -12,494,428 (-6.28%) | Filing History |
| 2024-01-24 12:51 pm Purchase | 2023-12-31 | 13G | KENVUE INC KVUE | JOHNSON & JOHNSON JNJ | 182,329,550 9.500% | 182,329,550 (New Position) | Filing History |
| 2023-02-10 07:53 am Sale | 2022-12-31 | 13G | JOHNSON AND JOHNSON JNJ | STATE STREET CORP STT | 142,447,944 5.450% | -2,548,183 (-1.76%) | Filing History |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | JOHNSON AND JOHNSON JNJ | VANGUARD GROUP INC | 246,826,621 9.440% | 12,043,989 (+5.13%) | Filing History |